The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123849544 12384954 4 F 20150903 20160920 20160519 20160927 EXP JP-ROCHE-1756779 ROCHE 74.66 YR F Y 0.00000 20160927 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123849544 12384954 1 PS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
123849544 12384954 2 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
123849544 12384954 3 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
123849544 12384954 4 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
123849544 12384954 5 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
123849544 12384954 6 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
123849544 12384954 7 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
123849544 12384954 8 SS Ranibizumab RANIBIZUMAB 1 Other 125156 .05 ML SOLUTION FOR INJECTION
123849544 12384954 9 C CRAVIT LEVOFLOXACIN 1 Ophthalmic BEFORE AND AFTER LUCENTIS ADMINISTRATION U 0
123849544 12384954 10 C CRAVIT LEVOFLOXACIN 1 Ophthalmic BEFORE AND AFTER LUCENTIS ADMINISTRATION U 0
123849544 12384954 11 C CRAVIT LEVOFLOXACIN 1 Ophthalmic BEFORE AND AFTER LUCENTIS ADMINISTRATION U 0
123849544 12384954 12 C CRAVIT LEVOFLOXACIN 1 Ophthalmic BEFORE AND AFTER LUCENTIS ADMINISTRATION U 0
123849544 12384954 13 C CRAVIT LEVOFLOXACIN 1 Ophthalmic BEFORE AND AFTER LUCENTIS ADMINISTRATION U 0
123849544 12384954 14 C CRAVIT LEVOFLOXACIN 1 Ophthalmic BEFORE AND AFTER LUCENTIS ADMINISTRATION U 0
123849544 12384954 15 C CRAVIT LEVOFLOXACIN 1 Ophthalmic BEFORE AND AFTER LUCENTIS ADMINISTRATION U 0
123849544 12384954 16 C CRAVIT LEVOFLOXACIN 1 Ophthalmic BEFORE AND AFTER LUCENTIS ADMINISTRATION U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123849544 12384954 1 Retinal vein occlusion
123849544 12384954 2 Macular oedema
123849544 12384954 9 Antibiotic prophylaxis

Outcome of event

Event ID CASEID OUTC COD
123849544 12384954 OT
123849544 12384954 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
123849544 12384954 Cerebral infarction
123849544 12384954 Visual acuity reduced

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123849544 12384954 1 20141218 0
123849544 12384954 2 20150305 0
123849544 12384954 3 20150402 0
123849544 12384954 4 20150507 0
123849544 12384954 5 20150604 0
123849544 12384954 6 20150702 0
123849544 12384954 7 20150806 0
123849544 12384954 8 20150903 20150903 0
123849544 12384954 9 20141218 0
123849544 12384954 10 20150305 0
123849544 12384954 11 20150402 0
123849544 12384954 12 20150507 0
123849544 12384954 13 20150604 0
123849544 12384954 14 20150702 0
123849544 12384954 15 20150806 0
123849544 12384954 16 20150903 0